AAAAAA
Results:
1-11
|
Results: 11
Authors:
Rintelen, C
Pabinger, I
Bettelheim, P
Lechner, K
Kyrle, PA
Knobl, P
Schneider, B
Mannhalter, C
Citation: C. Rintelen et al., Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation, EUR J HAEMA, 67(3), 2001, pp. 165-169
Authors:
Endler, G
Kyrle, PA
Eichinger, S
Exner, M
Mannhalter, C
Citation: G. Endler et al., Multiplexed mutagenically separated PCR: Simultaneous single-tube detection of the factor V R506Q (G1691A), the prothrombin G20210A, and the methylenetetrahydrofolate reductase A223V (C67TT) variants, CLIN CHEM, 47(2), 2001, pp. 333-335
Authors:
Kyrle, PA
Minar, E
Hirschl, M
Bialonczyk, C
Stain, M
Schneider, B
Weltermann, A
Speiser, W
Lechner, K
Eichinger, S
Citation: Pa. Kyrle et al., High plasma levels of factor VIII and the risk of recurrent venous thromboembolism., N ENG J MED, 343(7), 2000, pp. 457-462
Authors:
Kyrle, PA
Eichinger, S
Citation: Pa. Kyrle et S. Eichinger, High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. Reply, N ENG J MED, 343(26), 2000, pp. 1968-1969
Authors:
Eichinger, S
Kyrle, PA
Pabinger, I
Lechner, K
Citation: S. Eichinger et al., The risk of recurrent venous thromboembolic disease - implications for treatment, ACUTE PULMONARY EMBOLISM, 2000, pp. 155-160
Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo
Authors:
Weltermann, A
Wolzt, M
Petersmann, K
Czerni, C
Graselli, U
Lechner, K
Kyrle, PA
Citation: A. Weltermann et al., Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo, ART THROM V, 19(7), 1999, pp. 1757-1760
Authors:
Rintelen, C
Mannhalter, C
Lechner, K
Eichinger, S
Kyrle, PA
Papagiannopoulos, M
Schneider, B
Pabinger, I
Citation: C. Rintelen et al., No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene, BL COAG FIB, 10(2), 1999, pp. 101-105
Authors:
Eichinger, S
Weltermann, A
Philipp, K
Hafner, E
Kaider, A
Kittl, EM
Brenner, B
Mannhalter, C
Lechner, K
Kyrle, PA
Citation: S. Eichinger et al., Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden, THROMB HAEM, 82(4), 1999, pp. 1232-1236
Authors:
Eichinger, S
Minar, E
Hirschl, M
Bialonczyk, C
Stain, M
Mannhalter, C
Stumpflen, A
Schneider, B
Lechner, K
Kyrle, PA
Citation: S. Eichinger et al., The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene, THROMB HAEM, 81(1), 1999, pp. 14-17
Authors:
Quehenberger, P
Handler, S
Mannhalter, C
Kyrle, PA
Speiser, W
Citation: P. Quehenberger et al., The Factor V (Leiden) Test: Evaluation of an assay based on dilute RussellViper Venom Time for the detection of the Factor V Leiden mutation, THROMB RES, 96(2), 1999, pp. 125-133
Authors:
Male, C
Lechner, K
Eichinger, S
Kyrle, PA
Kapiotis, S
Wank, H
Kaider, A
Pabinger, I
Citation: C. Male et al., Clinical significance of lupus anticoagulants in children, J PEDIAT, 134(2), 1999, pp. 199-205
Risultati:
1-11
|